Top Story

HIV replicates in brain, CNS shortly after infection

March 30, 2015

HIV may begin replicating within a patient’s brain and central nervous system as soon as 4 months after infection, according to data recently published in PLoS Pathogens.

“While HIV-1 can be detected in both the cerebrospinal fluid (CSF) and brain tissue during the weeks after initial exposure,” the researchers wrote, “it is unknown when the virus actually begins replicating independently in the central nervous system (CNS).”

APIC commends researcher for hand hygiene study

March 29, 2015
Jorge Parada, MD, epidemiologist and medical director at Loyola University Health System, will be honored by the Association for Professionals in Infection Control…

WHO outlines 'End TB Strategy'

March 28, 2015
In an article recently published in The Lancet, WHO researchers outlined and detailed the organization’s new strategy to achieve worldwide eradication of…
In the Journals

Younger children have highest mortality rate for Ebola

March 27, 2015
Children aged younger than 5 years are more likely to die from Ebola and experience faster progressing illness vs. adults, according to study findings discussed in a…

White House releases 5-year strategy to combat antibiotic resistance

March 27, 2015
The White House released a report today outlining the government’s plans to reduce the threat of antibiotic-resistant bacteria during the next 5 years. Developed…
More News Headlines »
CME
Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

This activity is supported by an educational grant from Alcon Research, LTD.

More »
Meeting News Coverage Video
thumbnail for video 4129869191001

Video: NIAID Ebola vaccine well tolerated, immunogenic

March 23, 2015
WILMINGTON, Del. — Julie Ledgerwood, DO, of the National Institute of Allergy and Infectious Diseases' Vaccine…
More »
CME CNE CPE Video
Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

This activity is supported by an educational grant from Bristol-Myers Squibb.

Protease inhibitors (PIs) have played an instrumental role in decreasing mortality andmorbidity among HIV-infected…
More »
morganatic-roan
morganatic-roan